A detailed history of Goldman Sachs Group Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,426,999 shares of ELAN stock, worth $17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,426,999
Previous 2,834,727 49.66%
Holding current value
$17 Million
Previous $40.9 Million 48.79%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.85 - $15.47 $16.7 Million - $21.8 Million
-1,407,728 Reduced 49.66%
1,426,999 $20.9 Million
Q2 2024

Aug 13, 2024

BUY
$12.93 - $18.45 $22.1 Million - $31.6 Million
1,711,256 Added 152.32%
2,834,727 $40.9 Million
Q1 2024

May 15, 2024

SELL
$14.37 - $16.46 $1.37 Million - $1.57 Million
-95,264 Reduced 7.82%
1,123,471 $18.3 Million
Q4 2023

Feb 13, 2024

SELL
$8.6 - $14.94 $37 Million - $64.3 Million
-4,307,126 Reduced 77.94%
1,218,735 $18.2 Million
Q3 2023

May 14, 2024

BUY
$9.81 - $12.62 $42.3 Million - $54.4 Million
4,307,126 Added 353.41%
5,525,861 $62.1 Million
Q3 2023

Nov 14, 2023

SELL
$9.81 - $12.62 $34 Million - $43.8 Million
-3,469,831 Reduced 38.57%
5,525,861 $62.1 Million
Q2 2023

May 14, 2024

SELL
$8.08 - $10.37 $6.9 Million - $8.85 Million
-853,570 Reduced 8.67%
8,995,692 $90.5 Million
Q2 2023

Aug 14, 2023

SELL
$8.08 - $10.37 $6.9 Million - $8.85 Million
-853,570 Reduced 8.67%
8,995,692 $90.5 Million
Q1 2023

May 14, 2024

SELL
$8.79 - $14.58 $4.87 Million - $8.07 Million
-553,804 Reduced 5.32%
9,849,262 $92.6 Million
Q1 2023

May 11, 2023

SELL
$8.79 - $14.58 $4.87 Million - $8.07 Million
-553,804 Reduced 5.32%
9,849,262 $92.6 Million
Q4 2022

May 14, 2024

BUY
$11.49 - $13.65 $97.6 Million - $116 Million
8,495,845 Added 445.46%
10,403,066 $127 Million
Q4 2022

Feb 13, 2023

BUY
$11.49 - $13.65 $97.6 Million - $116 Million
8,495,845 Added 445.46%
10,403,066 $127 Million
Q3 2022

May 14, 2024

SELL
$12.41 - $32.42 $102 Million - $268 Million
-8,252,019 Reduced 81.23%
1,907,221 $23.7 Million
Q3 2022

Nov 10, 2022

SELL
$12.41 - $32.42 $102 Million - $268 Million
-8,252,019 Reduced 81.23%
1,907,221 $23.7 Million
Q2 2022

May 14, 2024

BUY
$19.63 - $26.62 $176 Million - $238 Million
8,940,505 Added 733.59%
10,159,240 $199 Million
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $38.2 Million - $51.8 Million
-1,945,986 Reduced 16.08%
10,159,240 $199 Million
Q1 2022

May 16, 2022

BUY
$24.65 - $29.0 $38 Million - $44.7 Million
1,541,163 Added 14.59%
12,105,226 $316 Million
Q4 2021

Feb 14, 2022

BUY
$27.74 - $34.09 $30.9 Million - $37.9 Million
1,113,073 Added 11.78%
10,564,063 $300 Million
Q3 2021

Nov 10, 2021

BUY
$29.2 - $36.72 $276 Million - $347 Million
9,450,990 New
9,450,990 $301 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.